Dermatology

This site is intended for healthcare professionals only

Login Register

MD Brand Connect
Vaccine Hub
MDTV
Fact Check
Health Dialogues

Medical News & Guidelines
Health news
Fact Check
AYUSH
State News
Medical Education
Industry
MDTV

This site is intended for healthcare professionals only

Login Register

LoginRegister

Home
Medical news & Guidelines
Health news
Fact Check
AYUSH
State News
Medical Education
Industry

Farhat Nasim

Farhat Nasim joined Medical Dialogue an Editor for the Business Section in 2017. She Covers all the updates in the Pharmaceutical field, Policy, Insurance, Business Healthcare, Medical News, Health News, Pharma News, Healthcare and Investment. She is a graduate of St.Xavier’s College Ranchi. She can be contacted at editorial@medicaldialogues.in Contact no. 011-43720751

Home

Farhat Nasim

Articles By : Farhat Nasim

No bar on taking corrective measures if error occurs in fixing retail price of drugs: NPPA

Farhat Nasim28 Nov 2022 6:00 PM IST

New Delhi: There can be no bar on National Pharmaceutical Pricing Authority (NPPA) to take corrective measures if it finds out some inconsistency or...

Patient dies from suspected drug reaction to Emcure Pharma's Orofer FCM, Maha FDA issues nationwide recall

Farhat Nasim24 Nov 2022 5:48 PM IST

Pune: Drug maker Emcure Pharmaceuticals Ltd. has landed in trouble after a patient at Saifee Hospital administered iron supplement, Orofer FCM (ferric...

Apixaban patent Violation: HC reprimands BDR Pharma for callousness in implementing court order

Farhat Nasim24 Nov 2022 12:24 PM IST

New Delhi: Coming down heavily on BDR Pharmaceuticals International, the Delhi High Court has warned the Mumbai-based drug maker against its 'callous...

Dr Reddys Labs gets USFDA EIR for Miryalaguda facility

Dr Reddys beats Aurobindo Pharma to become second biggest drug maker in India: Report

Farhat Nasim22 Nov 2022 6:36 PM IST

New Delhi: A change in the ranking of India's USD 50 billion pharma industry in over 7 years was witnessed as Hyderabad-based Dr Reddy's...

Union Health Ministry notifies 300 drug brands under Schedule H2, Details

Farhat Nasim21 Nov 2022 5:38 PM IST

New Delhi: The Union Health Ministry has mandated Barcode or Quick Response (QR) Code on the label of top 300 brands of drugs including Dolo, Allegra,...

Fortis to onboard new 550-bed super specialty hospital in Lucknow

Proceed with Fortis open offer only after Delhi HC nod: SEBI to IHH

Farhat Nasim18 Nov 2022 4:30 PM IST

New Delhi: IHH Healthcare on Thursday said the Securities and Exchange Board of India (SEBI) has advised it to proceed with its stalled open offer to...

Permitting fake pharmacists to function, will be playing with life of citizens: SC pulls Bihar Govt

Farhat Nasim15 Nov 2022 5:59 PM IST

New Delhi: Opining that by permitting fake pharmacists to run medical stores, it will be playing with the life of the citizens, the Supreme Court has...

Odisha Pharmacy Council dissolved

Farhat Nasim15 Nov 2022 5:54 PM IST

Bhubaneswar: The Odisha Pharmacy Council (OPC) has been dissolved by the State Government, and all the present council members have been debarred from...

PCI to decide on applications of pharmacy institutions for grant of approval by Nov 15: SC

Farhat Nasim14 Nov 2022 6:00 PM IST

New Delhi: With respect to pharmacy institutions applying for approval, the Supreme Court has sought the Pharmacy Council of India (PCI) to take...

Indian Pharma Market registers 7.2 percent growth in October: AIOCD-AWACS Report

Farhat Nasim11 Nov 2022 6:00 PM IST

New Delhi: The Indian Pharmaceutical Market (IPM) has registered a decline in growth for the month of October as industry sales rose only 7.2 percent...

Freebies to Doctors Illegal: ITAT disallows Rs 1 crore business promotion expenses by Mankind Pharma on gift cards

Farhat Nasim9 Nov 2022 2:39 PM IST

The AO, during the assessment proceedings had noticed that Mankind Pharma had made payments to the doctors by way of gift cards which could be...

DoP Directs NPPA to consider Cipla application for retail price fixation of asthma drug combination

Farhat Nasim5 Nov 2022 6:00 PM IST

New Delhi: In a major respite to Cipla Ltd., embroiled in a legal battle for almost three years over the price of an Asthma inhaler drug, the...

Powered By: Hocalwire

X

We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok